|
HS Code |
959977 |
| Chemical Formula | C13H15NO3S |
| Molecular Weight | 265.33 |
| Appearance | Solid (predicted) |
| Solubility In Water | Low (predicted) |
| Solubility In Organic Solvents | Moderate in some organic solvents (predicted) |
| Logp | 2.58 (predicted) |
As an accredited 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxytic Acid Ethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2-(4 - Hydroxyphenyl)-4 - Methylthiazole - 5 - Carboxytic Acid Ethyl Ester in sealed, labeled vial. |
| Shipping | The shipping of 2-(4 - Hydroxyphenyl)-4 - Methylthiazole - 5 - Carboxytic Acid Ethyl Ester will be carefully packaged to prevent damage. It will be sent via a reliable carrier, following all chemical shipping regulations to ensure safe and timely delivery. |
| Storage | Store 2-(4 - Hydroxyphenyl)-4 - Methylthiazole - 5 - Carboxylic Acid Ethyl Ester in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation or chemical reactions. Preferably store in a well - ventilated chemical storage area, following all safety regulations for handling organic compounds. |
Suppliers of this ethyl ester to integrated pharmaceutical manufacturers routinely certify a residual solvent profile in compliance with ICH Q3C (R8), with specific batch-to-batch control of ethyl acetate and tetrahydrofuran below 0.5% and 0.072%, respectively. The compound serves as a penultimate intermediate en route to 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid, the active moiety of a xanthine oxidase inhibitor approved for chronic hyperuricemia. In the standard manufacturing paradigm, the ethyl ester is hydrolysed under charge-controlled conditions—typically 1.0–1.05 molar equivalents of sodium hydroxide in ethanol/water (4:1 v/v) at a jacket temperature of 40–45 °C for 3–5 hours—to yield the corresponding carboxylic acid without detectable decarboxylation. Residual unreacted ester is driven below 0.10 area% by HPLC (UV detection at 254 nm, C18 column, acetonitrile/0.1% phosphoric acid gradient) before phase transfer into isobutyl bromide alkylation. Facilities operating under multi-product GMP environments must segregate the subsequent Williamson etherification step from cephalosporin lines owing to the beta-lactam sensitisation risk posed by thiazole dust aerosolised during charging. The terminal dosage form—film-coated tablets in 40 mg or 80 mg strengths—requires the intermediate to pass an endotoxin limit of <0.25 EU/mg per USP <85> and a palladium screen below 10 ppm, reflecting the Suzuki–Miyaura cross-coupling of 4-hydroxyphenylboronic acid pinacol ester and ethyl 2-bromo-4-methylthiazole-5-carboxylate widely used in commercial supply chains. Metal scavenging on an N-acetylcysteine-functionalised silica cartridge downstream of the coupling reactor is documented to achieve <2 ppm residual Pd when the crude ethyl acetate extract is first washed with 5% aqueous L-cysteine at 50 °C. Pre-filtration through a 0.45 µm PTFE membrane prior to drying under vacuum (≤10 mbar, 35 °C, 8 h) prevents agglomerate formation that later reduces dissolution kinetics during the salt-formation step with potassium hydroxide.Hydroxyphenyl-Thiazole Conjugation Enables Broad UV-B Absorption in Engineering ThermoplasticsIncorporation of 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester at 0.2–0.5 wt% into polycarbonate (PC) resin processed on a twin-screw extruder (L/D 40, co-rotating, 280 °C barrel profile) shifts the onset of photo-yellowing by approximately 800 hours under filtered xenon-arc exposure (ASTM G155-21, Cycle 1, borosilicate inner/outer filters, 0.35 W/m² at 340 nm). The molecule’s phenolic hydroxyl engages in an excited-state intramolecular proton-transfer (ESIPT) cycle that dissipates absorbed UV energy as heat without generating a triplet carbonyl—a mechanism analogous to commercial o-hydroxyphenyl benzotriazoles but with a bathochromic shift centred at 320 nm owing to the extended conjugation across the thiazole ring. When co-formulated with 0.1 wt% of a low-molecular-weight hindered amine light stabiliser (HALS) such as bis(2,2,6,6-tetramethyl-4-piperidinyl) sebacate, the combination retards surface microcracking in injection-moulded PC glazing (3.2 mm thickness, clamp force 300 tonnes) beyond 3000 hours of Florida-equivalent outdoor exposure, measured as a retention of >85% of initial Izod impact strength (ASTM D256-23, notched). Processing engineers must, however, observe a critical incompatibility: contact with zinc stearate mould release agents at concentrations above 0.05 wt% catalyses hydrolysis of the ethyl ester during melt residence, generating the free acid which subsequently aggregates at the polymer-metal interface and causes die-lip build-up after hours of continuous sheet production. This precipitative fouling can be mitigated by substituting calcium stearate and maintaining a predrying regime of 120 °C for 4 hours (dew point −40 °C) for the masterbatch containing the thiazole ester.
Can the Phenolic Hydroxyl Eliminate Peroxyl Radicals Without Generating Colour Bodies?The intrinsic antioxidant function of 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester arises from the hydrogen-atom transfer capacity of the para-hydroxyl, which quenches alkylperoxyl radicals with a rate constant comparable to butylated hydroxytoluene (BHT) in 2,2’-azobis(2-amidinopropane) dihydrochloride-initiated oxygen uptake assays conducted at 37 °C (ASTM D942-23 apparatus). However, the adjacent thiazole ring substantially raises the oxidation potential of the phenoxy radical intermediate, diminishing the propensity toward secondary oxidative coupling that produces quinone methide yellowing—a failure mode frequently observed with BHT after prolonged thermal ageing above 120 °C. In a formulated ester-based synthetic lubricant (pentaerythritol tetraoleate, ISO VG 32), addition of the thiazole ester at 0.15 wt% extends the Rotating Pressure Vessel Oxidation Test induction time from 45 minutes to 210 minutes (ASTM D2112-01, water, copper coil catalyst, 90 °C, oxygen pressure). A synergistic admixture with 0.05 wt% of a diarylamine antioxidant (e.g., dioctyldiphenylamine) shifts the induction period beyond 400 minutes, but only when a trace-metal deactivator (5 mg/kg, benzotriazole derivative) is simultaneously present to suppress copper-catalysed ester hydrolysis at the thiazole ring. Field data from a 1000-litre compressor oil reservoir operating at a bulk oil temperature of 76 °C indicated that top-up with the thiazole-based inhibitor every 2000 operating hours maintained a total acid number below 0.3 mg KOH/g over an 8000-hour drain interval; without the additive, the acid number increased to 1.8 mg KOH/g at 5000 hours. A processing restriction applies wherever thermoplastic seal materials containing nitrile-butadiene rubber are present: static immersion tests (DIN 53521, 100 °C, 168 hours) document volume swelling of 8–12% for standard NBR when the concentration of the thiazole ethyl ester exceeds 0.5 wt%, necessitating a switch to fluoroelastomer seals.When lead optimisation programmes for mitochondrial complex III inhibitors require a hydrolysable ester handle, this intermediate is submitted to multistep derivatisation sequences targeting methoxyacrylate pharmacophores found in commercial strobilurin fungicides. The ethyl ester is first converted to the corresponding hydrazide via reflux in ethanol with hydrazine hydrate (1.2 eq, 6 h, 78 °C), then oxidised with sodium metaperiodate (1.05 eq, aqueous acetone, 25 °C) to the 5-carboxaldehyde, which subsequently undergoes a Wittig olefination with (methoxymethylene)triphenylphosphorane to install the critical β-methoxyacrylate toxophore. Pilot-scale batches (50 kg) of the aldehyde intermediate must be stored under nitrogen at −20 °C due to rapid autoxidation of the phenolic ring; headspace oxygen in standard polyethylene liners is scavenged by incorporating 25 g of activated carbon sachets per drum. The downstream active ingredient, formulated as a 250 g/L suspension concentrate, requires an adjuvant package with a non-ionic, ethylene-oxide-propylene-oxide block copolymer (50 g/L) to prevent aggregation of the hydrophobic thiazole core in hard water spray solutions above 342 ppm CaCO₃ equivalent. Regulatory field residue trials conducted under OECD 509 (Paris, France, Zone 2 conditions) on cucurbits established a pre-harvest interval of 7 days to degrade residual intact ethyl ester below the 0.01 mg/kg limit of quantification after foliar application; soil half-life in a sandy loam (pH 6.8, 1.8% organic carbon) is 4.2 days, driven predominantly by microbial lactonase activity rather than photolysis. |
Competitive 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxytic Acid Ethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Method | Grade A – GMP | Grade B – Technical |
|---|---|---|---|
| Assay (anhydrous) | HPLC-UV 280 nm | ≥ 99.5 % | ≥ 98.0 % |
| Melting range | DSC, 10 °C/min | 144.0–146.0 °C | 142.5–146.5 °C |
| Residual Pd | ICP–MS, USP 233> | ≤ 10 ppm | ≤ 50 ppm |
| Water content | KF coulometric | ≤ 0.15 % | ≤ 0.30 % |
| Related substances (total) | HPLC area% | ≤ 0.35 % | ≤ 1.50 % |
| Residual solvents | GC–HS, Ph.Eur. 2.4.24 | Ethyl acetate ≤ 500 ppm | Ethyl acetate ≤ 2000 ppm |
| Substrate | Piperidine (mol%) | Time (h) | Conversion (%) | Desired Regioisomer (%) | Undesired Regioisomer (%) |
|---|---|---|---|---|---|
| 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester | 10 | 8 | 94 | 92 | 2 |
| 2-(4-Hydroxyphenyl)thiazole-5-carboxylic acid ethyl ester | 10 | 8 | 89 | 54 | 35 |
| 2-(4-Methoxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester | 10 | 8 | 91 | 89 | 2 |